New Dallas Police Chief Daniel Comeaux pledges to work with federal agencies on immigration enforcement in departure from ...

City Manager Kim Tolbert announced this week that Daniel Comeaux, currently the Special ... the Houston Police Department before joining the DEA in 1997. In his current role, he oversees ...

“Being a former Houston policeman, I felt like it was a perfect fit for me,” Comeaux said. DEA Special Agent in Charge Daniel Comeaux talks to his colleagues as he eats at Burns Original BBQ ...

New Dallas Police Chief Daniel Comeaux has headed the DEA's Houston office, and he beat out four finalists to replace former Chief Eddie Garcia after a three-month national search. Dallas’ next ...

New Dallas Police Chief Daniel Comeaux said Wednesday that the department's stance on the issue "hasn't changed." ...

Daniel Comeaux, a 33-year law enforcement veteran and current DEA special agent, has been named the next chief of the Dallas Police Department. Comeaux will take over on April 23, bringing ...

After a college football injury, Comeaux applied to become a Houston police officer in 1991. By August, he was in the academy. His path shifted again in 1997, he became a DEA agent — a decision ...

Daniel Comeaux will take over as the Dallas’ 31st ... according to the news release. He joined the DEA in 1997 and led major operations that targeted violent crime and drug trafficking, official ...

City Manager Kimberly Tolbert named Daniel C. Comeaux to the top job Friday ... He has been with the DEA since 1997, combating violent crime and drug trafficking. Comeaux started his career ...

Daniel Comeaux, head of the DEA’s Houston office, has been named the next chief of the Dallas Police Department. Dallas Mayor Eric Johnson announced the appointment in a press release, saying Comeaux ...

On Police Chief Daniel Comeaux’s first day, we chatted with him about the move to Dallas, goals for the future and what to expect.

DEA’s Houston Division Special Agent in Charge Daniel Comeaux displays photos of a pill made by a drug cartel, left, and one made by a pharmaceutical manufacturer, right, during a press ...